Kuwait has introduced stricter rules for medicine promotion and interactions between pharmaceutical companies and health officials at Ministry of Health facilities.
Health Minister Dr Ahmad Al-Awadhi issued the ministerial decision as part of efforts to strengthen oversight of medicines and medical products.
The new framework also aims to encourage their responsible use and establish clearer standards for communication within healthcare facilities.
New Rules for Pharmaceutical Representatives
Under the new Kuwait medicine promotion rules, pharmaceutical representatives must schedule their visits in advance.
They also need approval from the relevant authority before visiting Ministry of Health facilities.
In addition, representatives must hold valid professional permits. They can conduct their activities only in approved meeting areas and designated medical-education spaces.
These measures aim to make interactions between pharmaceutical companies and healthcare professionals more structured and transparent.
Direct Contact With Patients Prohibited
The new regulations place clear limits on how company representatives can interact with patients.
Representatives cannot communicate directly with patients during their activities at Ministry of Health facilities.
They are also prohibited from accessing patients’ health information.
This requirement strengthens privacy protections and helps separate commercial promotion from direct patient care.
Official Channels Required
The regulations also introduce tighter controls for communication with technical committees and procurement departments.
Pharmaceutical companies and their representatives must use official channels when dealing with these bodies.
As a result, the ministry expects the new system to improve transparency around medicines and medical-product procurement.
Promotional Materials Face Greater Scrutiny
The ministry has also established requirements for promotional content.
All promotional materials must receive the necessary approval before representatives can use them.
Furthermore, information presented about medicines and medical products must meet several standards.
It must be:
- Accurate
- Balanced
- Properly documented
- Verifiable
These requirements are designed to ensure healthcare professionals receive reliable information when considering medicines and medical products.
Focus on Patient Safety
The new Kuwait medicine promotion rules form part of a wider effort to protect patients and improve professional practices.
By restricting direct contact with patients and access to their medical information, the regulations create a clearer boundary between pharmaceutical promotion and healthcare delivery.
At the same time, the ministry wants scientific communication between companies and healthcare professionals to remain useful and properly regulated.
Kuwait Strengthens Pharmaceutical Oversight
The Health Ministry said the measures will create a more professional and transparent environment for pharmaceutical and medical-product promotion.
The regulations also support the rational use of medicines and reinforce institutional standards across Ministry of Health facilities.
Overall, Kuwait’s latest decision signals a stronger focus on accountability, accurate medical information and patient safety in the pharmaceutical sector.
